Cargando…
The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019
The World Health Assembly in 2014 adopted a resolution that mandates both Member States and the WHO Secretariat to facilitate access to biotherapeutic products in a way that ensures their quality, safety and efficacy. The availability of biosimilars is expected to increase access to biotherapeutic p...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academic Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254057/ https://www.ncbi.nlm.nih.gov/pubmed/32224101 http://dx.doi.org/10.1016/j.biologicals.2020.02.005 |